News - Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Clinical Pharmacology

EXPLORE :

Most Read News

All News

All Webcasts / CME

All Cases

Congress Resource Centre

All Medical Resources

My Personal Edition

Warning | Privacy

Recent news - Clinical Pharmacology

	The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials - (BMJ)
	Recurrence up to 3.5 years after antibiotic treatment of acute otitis media in very young Dutch children: survey of trial participants - (BMJ)
	Topical Cream Effective Against Cetuximab-Induced Acne-Like Rash: Presented at ESMO-GI - (DGDispatch)
	Endocrine Society Responds to Insulin Glargine Studies With Recommendations - (DGNews)
	Two Bevacizumab-Based Combination Regimens Equally Effective in Patients With Metastatic Colorectal Cancer: Presented at ESMO-GI - (DGDispatch)

News archive

Recent webcasts/CME - Clinical Pharmacology

Biologics in Crohn's Disease: Treating Early, Treating Long-Term

	Urinalysis: A Guide for Pharmacists
	Clinical Management of Nutrition in Hospitalized Patients: Improving Safety and Patient Outcomes
	Advances in the Management of Postoperative Ileus: Reducing the Clinical and Economic Burden
	The Challenge of Type 2 Diabetes: Emerging Options for Improving Glycemic Control

Webcasts/CME archive

Recent cases - Clinical Pharmacology

	Bilateral Swollen Eyelids Occurring During Adjuvant Treatment with Tamoxifen for Early Breast Cancer
	Acute Abdominal Pain in a Patient Receiving Enoxaparin
	Fatal Pneumonitis After Treatment with Docetaxel and Trastuzumab
	Cardiogenic Shock Caused by Disulfiram
	Clopidogrel Resistance "Live" - The Risk of Stent Thrombosis Should Be Evaluated Before Procedures

Cases archive

my personal edition > clinical pharmacology > news

E-Mail this DGNews to a colleague

DGNews

Pioglitazone Hydrochloride Approved as Concomitant Therapy With Biguanides for Type 2 Diabetes in Japan

NEW YORK -- December 22, 2008 -- An additional indication of concomitant therapy with biguanides has been approved for pioglitazone hydrochloride (Actos) by the Ministry of Health, Labour, and Welfare in Japan, for the treatment of type 2 diabetes.

The approval is based on a randomised, double-blind, comparative study, in which the clinical usefulness of biguanides monotherapy was compared with that of biguanides plus pioglitazone hydrochloride.

Patients receiving biguanides plus pioglitazone hydrochloride showed a statistically significant difference in improving HbA1C without increasing the risk of hypoglycaemia.

Management of type 2 diabetes should also include nutritional counselling, weight reduction as needed, and exercise.

SOURCE: Takeda Pharmaceutical Company Limited

E-Mail this DGNews to a colleague To print, use this version